Anti-DMTA2/ DMRTA2 functional antibody
Anti-DMTA2/ DMRTA2 functional antibody for cell culture, ELISA & in-vivo assay
Go to DMRTA2/DMRTA2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-SE1520-Ab-1/ GM-Tg-hg-SE1520-Ab-2 | Anti-Human DMRTA2 monoclonal antibody | Human |
GM-Tg-rg-SE1520-Ab-1/ GM-Tg-rg-SE1520-Ab-2 | Anti-Rat DMRTA2 monoclonal antibody | Rat |
GM-Tg-mg-SE1520-Ab-1/ GM-Tg-mg-SE1520-Ab-2 | Anti-Mouse DMRTA2 monoclonal antibody | Mouse |
GM-Tg-cynog-SE1520-Ab-1/ GM-Tg-cynog-SE1520-Ab-2 | Anti-Cynomolgus/ Rhesus macaque DMRTA2 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-SE1520-Ab-1/ GM-Tg-felg-SE1520-Ab-2 | Anti-Feline DMRTA2 monoclonal antibody | Feline |
GM-Tg-cang-SE1520-Ab-1/ GM-Tg-cang-SE1520-Ab-2 | Anti-Canine DMRTA2 monoclonal antibody | Canine |
GM-Tg-bovg-SE1520-Ab-1/ GM-Tg-bovg-SE1520-Ab-2 | Anti-Bovine DMRTA2 monoclonal antibody | Bovine |
GM-Tg-equg-SE1520-Ab-1/ GM-Tg-equg-SE1520-Ab-2 | Anti-Equine DMRTA2 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-SE1520-Ab-1/ GM-Tg-hg-SE1520-Ab-2; GM-Tg-rg-SE1520-Ab-1/ GM-Tg-rg-SE1520-Ab-2; GM-Tg-mg-SE1520-Ab-1/ GM-Tg-mg-SE1520-Ab-2; GM-Tg-cynog-SE1520-Ab-1/ GM-Tg-cynog-SE1520-Ab-2; GM-Tg-felg-SE1520-Ab-1/ GM-Tg-felg-SE1520-Ab-2; GM-Tg-cang-SE1520-Ab-1/ GM-Tg-cang-SE1520-Ab-2; GM-Tg-bovg-SE1520-Ab-1/ GM-Tg-bovg-SE1520-Ab-2; GM-Tg-equg-SE1520-Ab-1/ GM-Tg-equg-SE1520-Ab-2 |
Products Name | Anti-DMRTA2 monoclonal antibody |
Format | mab |
Target Name | DMRTA2 |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-DMRTA2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-SE1520-Ag-1 | Recombinant multi-species DMTA2/ DMRTA2 protein |
Target information
Target ID | GM-SE1520 |
Target Name | DMRTA2 |
Gene ID | 63950,242620,313471,714181,100856321,101090787,537680,100147531 |
Gene Symbol and Synonyms | Dmrt5,DMRTA2 |
Uniprot Accession | Q96SC8,A6QQ94 |
Uniprot Entry Name | DMTA2_HUMAN,DMTA2_BOVIN |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000142700 |
Target Classification | N/A |
The target: DMRTA2, gene name: DMRTA2, also named as . Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II and sex differentiation. Predicted to act upstream of or within nervous system development and skeletal muscle cell differentiation. Predicted to be part of chromatin. Predicted to be active in nucleus..
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.